Li Y, Dou Y, Leprevost F da V, et al. Proteogenomic data and resources for pan-cancer analysis. Cancer cell. 2023;41(8):1397-1406. doi:10.1016/j.ccell.2023.06.009
Publications
Li Y, Porta-Pardo E, Tokheim C, et al. Pan-cancer proteogenomics connects oncogenic drivers to functional states. Cell. 2023. doi:10.1016/j.cell.2023.07.014
Geffen Y, Anand S, Akiyama Y, et al. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation. Cell. 2023. doi:10.1016/j.cell.2023.07.013
Liang WW, Lu RJH, Jayasinghe RG, et al. Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin. Cancer cell. 2023. doi:10.1016/j.ccell.2023.07.013
Benson MD, Eisman AS, Tahir UA, et al. Protein-metabolite association studies identify novel proteomic determinants of metabolite levels in human plasma. Cell metabolism. 2023. doi:10.1016/j.cmet.2023.07.012
Wang JM, Hong R, Demicco EG, et al. Deep learning integrates histopathology and proteogenomics at a pan-cancer level. Cell reports. Medicine. 2023:101173. doi:10.1016/j.xcrm.2023.101173
Kim MS, Song M, Kim B, et al. Prioritization of therapeutic targets for dyslipidemia using integrative multi-omics and multi-trait analysis. Cell reports. Medicine. 2023:101112. doi:10.1016/j.xcrm.2023.101112
Hudson L, Mason JW, Westphal M V, et al. Diversity-oriented synthesis encoded by deoxyoligonucleotides. Nature communications. 2023;14(1):4930. doi:10.1038/s41467-023-40575-5
Meadows JRS, Kidd JM, Wang GD, et al. Genome sequencing of 2000 canids by the Dog10K consortium advances the understanding of demography, genome function and architecture. Genome biology. 2023;24(1):187. doi:10.1186/s13059-023-03023-7
Tao Y, Lamas V, Du W, et al. Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo. Nature communications. 2023;14(1):4928. doi:10.1038/s41467-023-40476-7